NAUTILUS BIOTECHNOLOGY INC
NAUT · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $2.34
- Today’s Low
- $2.00
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.16
- Previous Close
- $2.17
- Volume
- 13.55M
- Market Cap
- $276.14M
- P/E Ratio
- --
- EPS
- $-0.44
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2701 EASTLAKE AVENUE EAST, SEATTLE, WA, UNITED STATES, 98102
- Country
- US
- Listing Date
- 2020-08-07
- Fiscal Year End
- December
- Shares Outstanding
- 127.26M
- CIK
- 0001808805
- Website
- www.nautilus.bio
Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome complexity. The company is headquartered in Seattle, Washington.
Financial Metrics
Revenue
2026-06-30
$190K
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$17.08M
2026-03-31
$14.64M
2025-12-31
$13.83M
2025-09-30
$15.47M
Net Income
2026-06-30
-$14.46M
2026-03-31
-$14.69M
2025-12-31
-$13.78M
2025-09-30
-$13.57M
Net Profit Margin
2026-06-30
-7.61K%
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.11
2026-03-31
$-0.12
2025-12-31
$-0.11
2025-09-30
$-0.11
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$14.47M
2026-03-31
-$13.22M
2025-12-31
-$12.19M
2025-09-30
-$13.84M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $190K | $0 | $0 | $0 |
| Operating Expenses | $17.08M | $14.64M | $13.83M | $15.47M |
| Net Income | -$14.46M | -$14.69M | -$13.78M | -$13.57M |
| Net Profit Margin | -7.61K% | -- | -- | -- |
| Earnings Per Share | $-0.11 | $-0.12 | $-0.11 | $-0.11 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$14.47M | -$13.22M | -$12.19M | -$13.84M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.